To determine whether the oncometabolite (R)-2-hydroxyglutarate (2-HG), which is produced by IDH1 mutant, was responsible for the increased CD73 expression, we cultured PBMCs for 72 hours with 2-HG concentrations typically found in patients with glioma (12, 13). This evidence concerns the gene NT5E and central nervous system cancer.